Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform in preparation for the upcoming Article 2(3) of Directive 2010/84/EU that will impact the pharmaceutical industry later this year. The data-focused clinical research organization (CRO) has made the move following the European Medicines Agency’s (EMA) planned launch of…